Double Trigger in Patients With Low Proportion of Mature Oocytes

• Status: Recruiting
• Trial end date: 2021-02-02
• Target enrollment: 0
• Participant gender: Female

Summary

The aim of this randomized controlled trial is to determine whether co-administration of GnRH agonist and hCG for final oocyte maturation ( 40 and 34 h prior to oocyte retrieval , respectively) can increase the number of mature oocytes in patients with history of low proportion of mature oocytes in previous IVF cycle triggered by HCG.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Riyadh Fertility and Reproductive Health center

Criteria

Inclusion Criteria:

• Patients with history of low proportion of mature oocytes in previous IVF attempt (triggered by HCG).

• Patients with 6 to 15 mature follicles on the day oocyte trigger in the current IVF-ET attempt

Exclusion Criteria:

• Endometriosis

• PCOS